REKLAMA
WAKACJE NA GIEŁDZIE

KRKA: Acquisition of treasury shares

2026-07-24 11:06
publikacja
2026-07-24 11:06
Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Detailed report on acquisition of treasury shares.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

33

/

2026

Date of issue:

2026-07-24

Short name of the issuer

KRKA

Subject

Acquisition of treasury shares

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces:

With a reference to the public notice from 20 July 2026, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 21 July 2026 up to and including 23 July 2026. Krka acquired 3,693 treasury shares in the total value of EUR 961,806 on the Ljubljana Stock Exchange as follows:

- on 21 July 2026: 1,139 shares at a VWAP of EUR 260.10,

- on 22 July 2026: 1,264 shares at a VWAP of EUR 260.60 and

- on 23 July 2026: 1,290 shares at a VWAP of EUR 260.58.

Price is calculated as volume weighted average price (VWAP).

Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.

The total number of treasury shares prior to these transactions was 2,516,581 representing 7.674% of all shares issued.

The total number of treasury shares after these transactions is 2,520,274 representing 7.685% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 24 July 2026 onwards, for a minimum period of 5 years.

Annexes

File

Description

Detailed report on acquisition of treasury shares.pdf

Detailed report on acquisition of treasury shares

Legal framework

Type of information

TRANSD

Acquisition or disposal of an issuer’s own shares

RegulatoryData

Collection Body

PLKNF

Unique data record identifier

Type of submission

New (to be used for new information)

Voluntary information flag

Date or period covered [Date or beginning of the period to which the information relates]

2026-07-21

Date or period covered [Date or end of the period to which the information relates]

2026-07-23

Personal data flag

Macierzyste państwo członkowskie, w stosownych przypadkach

PL

DocumentReference

Język, w którym przekazano informacje

Oryginał (ORIG) czy tłumaczenie (TRAN)

Numer referencyjny pliku danych

PL

ORIG

SubmittingEntity

Submitting entity LEI

or

Submitting entity name - natural person

RelatedEntity/LegalPerson

Entity LEI

Size of the entity

Industry sector(s)

549300H9RLRTRTLRUZ73

Large group

(acc. NACE): C

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

6

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-07-24

Jože Colarič

President of the Management Board and CEO

Źródło:Komunikaty spółek (ESPI)
Tematy
Nie tylko 0 zł za konto. Sprawdź, które rachunki firmowe naprawdę się opłacają
Nie tylko 0 zł za konto. Sprawdź, które rachunki firmowe naprawdę się opłacają

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki